Back to mobile site

Medtronic, Inc. (MDT) PT Lowered to $85 at UBS, Neutral Rating Maintained

June 4, 2026 9:51 AM EDT Send to a Friend
UBS analyst Priya Sachdeva lowered the price target on Medtronic, Inc. (NYSE: MDT) to $85.00 (from $90.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login